Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Progress in Retinal and Eye Research
|
May 11, 2010
Nanoparticles for retinal gene therapy
Shannon M Conley, Muna I Naash
Experimental Eye Research
|
April 16, 2009
Focus on molecules: RDS
Shannon M Conley, Muna I Naash
Cold Spring Harbor Perspectives in Medicine
|
August 30, 2014
Gene therapy for PRPH2-associated ocular disease: challenges and prospects
Shannon M Conley, Muna I Naash
Advances in Experimental Medicine and Biology
|
March 26, 2014
Gene therapy for Stargardt disease associated with ABCA4 gene
Zongchao Han, Shannon M Conley, Muna I Naash
Investigative Ophthalmology & Visual Science
|
May 12, 2011
AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects
Zongchao Han, Shannon M Conley, Muna I Naash
Current Opinion in Molecular Therapeutics
|
October 3, 2008
Nonviral ocular gene therapy: assessment and future directions
Shannon M Conley, Xue Cai, Muna I Naash
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 7, 2015
Non-viral therapeutic approaches to ocular diseases: An overview and future directions
Rahel Zulliger, Shannon M Conley, Muna I Naash
Advances in Experimental Medicine and Biology
|
December 21, 2011
Mislocalization of oligomerization-incompetent RDS is associated with mislocalization of cone opsins and cone transducin
Shannon M Conley, Dibyendu Chakraborty, Muna I Naash
Biomaterials
|
June 26, 2013
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium
Adarsha Koirala, Shannon M Conley, Muna I Naash
Ophthalmic Genetics
|
April 18, 2009
RPE65: role in the visual cycle, human retinal disease, and gene therapy
Xue Cai, Shannon M Conley, Muna I Naash
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Progress in Retinal and Eye Research
|
May 11, 2010
Nanoparticles for retinal gene therapy
Shannon M Conley, Muna I Naash
Experimental Eye Research
|
April 16, 2009
Focus on molecules: RDS
Shannon M Conley, Muna I Naash
Cold Spring Harbor Perspectives in Medicine
|
August 30, 2014
Gene therapy for PRPH2-associated ocular disease: challenges and prospects
Shannon M Conley, Muna I Naash
Advances in Experimental Medicine and Biology
|
March 26, 2014
Gene therapy for Stargardt disease associated with ABCA4 gene
Zongchao Han, Shannon M Conley, Muna I Naash
Investigative Ophthalmology & Visual Science
|
May 12, 2011
AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects
Zongchao Han, Shannon M Conley, Muna I Naash
Current Opinion in Molecular Therapeutics
|
October 3, 2008
Nonviral ocular gene therapy: assessment and future directions
Shannon M Conley, Xue Cai, Muna I Naash
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 7, 2015
Non-viral therapeutic approaches to ocular diseases: An overview and future directions
Rahel Zulliger, Shannon M Conley, Muna I Naash
Advances in Experimental Medicine and Biology
|
December 21, 2011
Mislocalization of oligomerization-incompetent RDS is associated with mislocalization of cone opsins and cone transducin
Shannon M Conley, Dibyendu Chakraborty, Muna I Naash
Biomaterials
|
June 26, 2013
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium
Adarsha Koirala, Shannon M Conley, Muna I Naash
Ophthalmic Genetics
|
April 18, 2009
RPE65: role in the visual cycle, human retinal disease, and gene therapy
Xue Cai, Shannon M Conley, Muna I Naash
Page
of 9